☰

Danielle R. Cook, Ph.D. - Publications

Affiliations: 
2013 Pharmaceutical Sciences University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
General Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cook DR, Kang M, Martin TD, Galanko JA, Loeza GH, Trembath DG, Justilien V, Pickering KA, Vincent DF, Jarosch A, Jurmeister P, Waters AM, Hibshman PS, Campbell AD, Ford CA, et al. Aberrant expression and subcellular localization of ECT2 drives colorectal cancer progression and growth. Cancer Research. PMID 34737214 DOI: 10.1158/0008-5472.CAN-20-4218  0.488
2018 Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, Cook DR, Thokala R, Blouch K, McGettigan-Croce B, Zhang L, Konradt C, Cogdill AP, Panjwani MK, Jiang S, et al. Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas. Molecular Therapy Oncolytics. 11: 20-38. PMID 30306125 DOI: 10.1016/J.Omto.2018.08.002  0.308
2017 Martin TD, Cook DR, Choi MY, Li MZ, Haigis KM, Elledge SJ. A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. Cell Reports. 20: 427-438. PMID 28700943 DOI: 10.1016/J.Celrep.2017.06.061  0.333
2017 Yin Y, Boesteanu A, Xu C, Posey A, Cook D, Blouch K, McGettigan-Croce B, Mason N, June CH, Lin Z, Johnson LA. Combinatorial IL13Rα2 chimeric antigen receptor-T cells plus checkpoint blockade to treat solid tumors in murine and canine models. Journal of Clinical Oncology. 35: 152-152. DOI: 10.1200/Jco.2017.35.7_Suppl.152  0.371
2016 Fraietta JA, Beckwith KA, Patel PR, Ruella M, Zheng Z, Barrett DM, Lacey SF, Melenhorst JJ, McGettigan SE, Cook DR, Zhang C, Xu J, Do P, Hulitt J, Kudchodkar SB, et al. Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia. Blood. PMID 26813675 DOI: 10.1182/Blood-2015-11-679134  0.358
2014 Cook DR, Rossman KL, Der CJ. Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease. Oncogene. 33: 4021-35. PMID 24037532 DOI: 10.1038/Onc.2013.362  0.527
2013 Huff LP, Decristo MJ, Trembath D, Kuan PF, Yim M, Liu J, Cook DR, Miller CR, Der CJ, Cox AD. The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation. Genes & Cancer. 4: 460-75. PMID 24386507 DOI: 10.1177/1947601913514851  0.541
2011 Cook DR, Solski PA, Bultman SJ, Kauselmann G, Schoor M, Kuehn R, Friedman LS, Cowley DO, Van Dyke T, Yeh JJ, Johnson L, Der CJ. The ect2 rho Guanine nucleotide exchange factor is essential for early mouse development and normal cell cytokinesis and migration. Genes & Cancer. 2: 932-42. PMID 22701760 DOI: 10.1177/1947601912437035  0.537
2011 Anderson LD, Cook DR, Yamamoto TN, Berger C, Maloney DG, Riddell SR. Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma. Cancer Immunology, Immunotherapy : Cii. 60: 985-97. PMID 21461886 DOI: 10.1007/S00262-011-1009-3  0.337
2007 Anderson LD, Cook DR, Berger C, Maloney DG, Riddell SR. Use of Gene-Modified T-Cells as Antigen Presenting Cells (T-APC) for Vaccination Against Myeloma Antigens. Blood. 110: 2758-2758. DOI: 10.1182/Blood.V110.11.2758.2758  0.352
Show low-probability matches.